The CareVoice

The CareVoice

The CareVoice is a Shanghai-based early growth-stage health insurtech startup. It provides a mobile social platform with community-sourced ratings and recommendations on healthcare services.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

August 2019

The CareVoice raises a $10,000,000 series A round from LUN Partners Group, SOSV, Artesian Capital Management and DNA Capital.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Art Dicker

Investor

Diana Kam

Investor

Geoffrey Handley

Advisor

Jan Velich

Founder

Joshua Chi

Employee

Martin Coriat - CEO Confused.com

Advisor

Neil Liang

Founder

Nick Cakebread

Investor

nicolas macquin

Investor

Olivier Gremillon - AirBnB EMEA MD

Advisor

Olivier Milcamps - Healthcare Insurance Executive

Advisor

Sarah Deplace

Employee

Sebastien Gaudin 高赛

Board member

Thibault VIllet

Investor

天使谷AngelVest Group

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Catherine Shu
August 22, 2019
TechCrunch
The CareVoice, a Shanghai-based health insurance software startup with ambitions to expand throughout Asia, announced today that it has raised about $10 million in Series A funding. The investment was led by LUN Partners Group and an undisclosed global investment manager that specializes in financial services, with participation from DNA Capital and returning investors SOSV [...]
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.